Zenas BioPharma, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 10.0M | 5.0M | 0 | 0 |
| Cost of Goods Sold | 6K | 55.7M | 5.0M | 43.0M | 0 | 0 | 33.5M | 33.8M |
| Gross Profit | -6K | -55.7M | -5.0M | -43.0M | 10.0M | 5.0M | -33.5M | -33.8M |
| R&D Expenses | 60.4M | 222.4M | 34.4M | 43.0M | 34.9M | 49.2M | 33.5M | 33.8M |
| Operating Expenses | 77.3M | 182.3M | 47.6M | 12.1M | 47.3M | 60.6M | 7.5M | 5.9M |
| Operating Income | -77.3M | -238.0M | -52.6M | -55.2M | -37.3M | -55.6M | -41.0M | -39.7M |
| Other Income / Gains | -3.6M | -2.4M | 1.1M | 3.0M | 3.6M | 3.4M | 2.4M | 1.7M |
| Net Income | -81.0M | -240.4M | -51.5M | -52.2M | -33.6M | -52.6M | -38.6M | -38.0M |
| EPS (Diluted) | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 1.00 | 1.00 | 0 | 0 |
| General And Administrative Expenses | 16.9M | 17.1M | 13.2M | 11.3M | 12.4M | 11.5M | 7.3M | 5.4M |
| Selling And Marketing Expenses | 0 | -1.5M | 0 | 803K | 0 | 0 | 200K | 543K |
| Selling General And Administrative Expenses | 16.9M | 15.6M | 13.2M | 12.1M | 12.4M | 11.5M | 7.5M | 5.9M |
| Other Expenses | 0 | -55.7M | 0 | -43.0M | 0 | 0 | -33.5M | -33.8M |
| Cost And Expenses | 77.3M | 238.0M | 52.6M | 55.2M | 47.3M | 60.6M | 41.0M | 39.7M |
| Interest Income | 3.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 6.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 6K | 10K | 11K | 12K | 23K | 33K | 36K | 35K |
| Ebitda | -74.3M | -230.4M | -51.5M | -52.2M | -33.8M | -52.1M | -38.6M | -37.9M |
| Ebitdaratio | 0 | 0 | 0 | 0 | -3.376 | -10.428 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | -3.733 | -11.125 | 0 | 0 |
| Income Before Tax | -81.0M | -240.3M | -51.5M | -52.2M | -33.8M | -52.2M | -38.6M | -38.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | -3.378 | -10.435 | 0 | 0 |
| Income Tax Expense | 0 | 106K | 0 | 20K | -205K | 429K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | -3.357 | -10.521 | 0 | 0 |
| Epsdiluted | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 |
| Weighted Average Shs Out | 55.6M | 46.5M | 42.2M | 41.9M | 41.8M | 41.8M | 41.8M | 38.3M |
| Weighted Average Shs Out Dil | 55.6M | 46.5M | 42.2M | 41.9M | 41.8M | 41.8M | 41.8M | 38.3M |